Expert Edge: A View from ARUP’s Medical Directors
Our pathology experts offer insight into leading-edge technology and tests in the Expert Edge, a new Q & A series ARUP is placing in CAP Today. Nationally and internationally respected for their expertise, these specialists have made significant contributions in research and development, and serve as faculty at the University of Utah School of Medicine.
- The Challenges
and Advancements in Newborn Drug-Exposure Testing
Gwendolyn McMillin, PhD, Medical Director, Toxicology and Pharmacogenetics
Heads in the Cloud: Harnessing the Healing Power of Bioinformatics
Frederick Strathmann, PhD, Acting Scientific Director, BioComputing
Elaine Gee, PhD, Director, Bioinformatics
How Are Genetic Counselors Strengthening Lab Utilization Management?
Sara Brown, MS, LCGC, Genetic Counselor
Advancing NGSBased, Pathogen-Detection Testing
Robert Schlaberg, MD, Dr. Med, MPH, Medical Director, Microbial Amplified Detection, Virology and Fecal Chemistry, Assistant Medical Director, Molecular Infectious Disease
Heparin-Induced Thrombocytopenia: Is SRA the Gold Standard Test?
Kristi J. Smock, MD, Medical Director, Hemostasis & Thrombosis Laboratory
Improving Diagnostics for Detecting GI Pathogens
Marc Roger Couturier, PhD, D(ABMM), Medical Director, Microbial Immunology, Parasitology, and Infectious Disease Rapid Testing
Breakthrough Technology Spurs New Test: for Non-Small Cell Lung Cancer Patients
Wade Samowitz, MD, Medical Director, Solid Tumor Molecular Diagnostics and Histology, Staff Pathologist, Anatomic Pathology
Treatment for Cancer Care: New Circulating Cell-Free Tumor DNA (ctDNA) Technology
Mary Bronner, MD, Division Chief, Anatomic Pathology and Oncology
Digital Pathology: Transforming Pathology from a Qualitative to a Quantitative Science
Mohamed E. Salama, MD, Medical Director, Hematopathology and Immunohistochemistry Staining